Probe Set ID	Gene Symbol	Gene Title	
M05.2	GDF11	growth differentiation factor 11
M22.2	AE000170	No description available
E06.3	IL5	interleukin 5 (colony-stimulating factor, eosinophil)
M15.1	NRG1	neuregulin 1
E20.3	TNFRSF7	tumor necrosis factor receptor superfamily, member 7
D04.3	IL2RG	interleukin 2 receptor, gamma (severe combined immunodeficiency)
L10.1	ITGA2	integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
L04.3	CSF2RA	colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)
G20.4	CEBPB	CCAAT/enhancer binding protein (C/EBP), beta
K14.3	SEMA3A	sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
K15.4	CD3D	CD3D antigen, delta polypeptide (TiT3 complex)
G20.2	BCL2L1	BCL2-like 1
M09.2	NFKB1	nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)
K09.1	ACVR1B	activin A receptor, type IB
F21.1	POR	P450 (cytochrome) oxidoreductase
N18.4	AXIN1	axin 1
J19.2	ADAM8	a disintegrin and metalloproteinase domain 8
H06.2	GAS2	growth arrest-specific 2
E13.1	BMPR1B	bone morphogenetic protein receptor, type IB
I06.4	PTPN4	protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte)
F16.4	EMP3	epithelial membrane protein 3
F04.2	SOCS6	suppressor of cytokine signaling 6
C10.1	CD14	CD14 antigen
H11.2	CNTN1	contactin 1
F19.4	RELB	v-rel reticuloendotheliosis viral oncogene homolog B, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 (avian)
K16.2	TNFRSF13B	tumor necrosis factor receptor superfamily, member 13B
G18.3	EFNA4	ephrin-A4
K19.4	NOTCH1	Notch homolog 1, translocation-associated (Drosophila)
C07.2	IL18BP	interleukin 18 binding protein
I15.2	IL10RA	interleukin 10 receptor, alpha
F22.4	TFRC	transferrin receptor (p90, CD71)
F08.1	ECGF1	endothelial cell growth factor 1 (platelet-derived)
D13.1	CCR9	chemokine (C-C motif) receptor 9
L14.2	CDC25B	cell division cycle 25B
K08.1	TERF1	telomeric repeat binding factor (NIMA-interacting) 1
M14.3	CD86	CD86 antigen (CD28 antigen ligand 2, B7-2 antigen)
N19.3	ACVR2B	activin A receptor, type IIB
N18.1	AA699554	No description available
L16.3	FGF11	fibroblast growth factor 11
I08.3	SLAMF1	signaling lymphocytic activation molecule family member 1
D19.4	CKS2	CDC28 protein kinase regulatory subunit 2
L19.2	NTF3	neurotrophin 3
M14.4	STAU	staufen, RNA binding protein (Drosophila)
G22.2	K-ALPHA-1	tubulin, alpha, ubiquitous
F15.3	TGFBR1	transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kDa)
G13.3	FGF4	fibroblast growth factor 4 (heparin secretory transforming protein 1, Kaposi sarcoma oncogene)
D10.4	RAF1	v-raf-1 murine leukemia viral oncogene homolog 1
I12.3	CCR1	chemokine (C-C motif) receptor 1
E22.2	HLA-A	major histocompatibility complex, class I, A
I16.3	CCR7	chemokine (C-C motif) receptor 7
H10.2	EIF2AK2	eukaryotic translation initiation factor 2-alpha kinase 2
E21.2	SEMA4D	sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
N04.4	TGIF	TGFB-induced factor (TALE family homeobox)
H05.3	VEGFB	vascular endothelial growth factor B
F07.3	IL18	interleukin 18 (interferon-gamma-inducing factor)
H20.4	C21ORF33	chromosome 21 open reading frame 33
G08.2	TNFRSF1A	tumor necrosis factor receptor superfamily, member 1A
C12.2	INS	insulin
J13.2	CHRM5	cholinergic receptor, muscarinic 5
G13.1	PDGFRB	platelet-derived growth factor receptor, beta polypeptide
D13.3	EFNA5	ephrin-A5
M07.1	CXCR4	chemokine (C-X-C motif) receptor 4
M16.4	MPO	myeloperoxidase
J08.1	ITGB4	integrin, beta 4
N13.1	GPR31	G protein-coupled receptor 31
J18.4	JUND	jun D proto-oncogene
J09.2	IL3RA	interleukin 3 receptor, alpha (low affinity)
F16.3	MBP	myelin basic protein
J07.2	ANGPTL7	angiopoietin-like 7
N15.2	TLR1	toll-like receptor 1
N06.2	STRAP	serine/threonine kinase receptor associated protein
I05.3	MAPK3	mitogen-activated protein kinase 3
K14.2	PDCD11	programmed cell death 11
K06.2	SFRP5	secreted frizzled-related protein 5
F05.4	PRF1	perforin 1 (pore forming protein)
J16.1	NRP2	neuropilin 2
J06.4	SAP30	sin3-associated polypeptide, 30kDa
D18.4	CAV1	caveolin 1, caveolae protein, 22kDa
J19.3	IL9	interleukin 9
I07.2	PAWR	PRKC, apoptosis, WT1, regulator
F11.4	DHH	desert hedgehog homolog (Drosophila)
J10.4	PCAF	p300/CBP-associated factor
G11.3	RTN4	reticulon 4
J18.3	CCL17	chemokine (C-C motif) ligand 17
F09.3	TNFSF8	tumor necrosis factor (ligand) superfamily, member 8
J15.3	CXCL10	chemokine (C-X-C motif) ligand 10
I19.3	CSF1	colony stimulating factor 1 (macrophage)
J10.3	BUB1	BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast)
H13.2	JAG2	jagged 2
J17.1	EPHA7	EphA7
E04.2	RBL1	retinoblastoma-like 1 (p107)
I11.1	ENG	endoglin (Osler-Rendu-Weber syndrome 1)
N10.4	RHOB	ras homolog gene family, member B
I20.4	PAK3	p21 (CDKN1A)-activated kinase 3
M13.3	CSF2	colony stimulating factor 2 (granulocyte-macrophage)
F13.1	STK17A	serine/threonine kinase 17a (apoptosis-inducing)
I06.1	MMP7	matrix metalloproteinase 7 (matrilysin, uterine)
I10.3	IL15	interleukin 15
H13.4	PTCH2	patched homolog 2 (Drosophila)
I20.3	FGF14	fibroblast growth factor 14
D07.1	TNFRSF21	tumor necrosis factor receptor superfamily, member 21
H04.3	ICOSLG	inducible T-cell co-stimulator ligand
E18.4	FAP	fibroblast activation protein, alpha
C16.3	CD28	CD28 antigen (Tp44)
D15.2	TLR2	toll-like receptor 2
L07.1	CXCL5	chemokine (C-X-C motif) ligand 5
M20.1	TNFRSF1B	tumor necrosis factor receptor superfamily, member 1B
H10.4	S100A1	S100 calcium binding protein A1
J07.3	BMP6	bone morphogenetic protein 6
I17.1	TNFRSF11B	tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin)
H06.4	AXIN2	axin 2 (conductin, axil)
I09.4	SKI	v-ski sarcoma viral oncogene homolog (avian)
C06.2	PIK3C2G	phosphoinositide-3-kinase, class 2, gamma polypeptide
L05.1	TYRO3	TYRO3 protein tyrosine kinase
K17.3	PCSK6	proprotein convertase subtilisin/kexin type 6
N07.2	NOTCH4	Notch homolog 4 (Drosophila)
M12.2	CCL22	chemokine (C-C motif) ligand 22
K19.3	MIF	macrophage migration inhibitory factor (glycosylation-inhibiting factor)
M04.2	CCNA2	cyclin A2
G04.4	AURKB	aurora kinase B
L12.1	ITGA5	integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
J16.2	ADAM12	a disintegrin and metalloproteinase domain 12 (meltrin alpha)
H15.1	EFNB1	ephrin-B1
F08.2	FNTB	farnesyltransferase, CAAX box, beta
E06.1	TNFSF11	tumor necrosis factor (ligand) superfamily, member 11
L19.1	GPR24	G protein-coupled receptor 24
G12.3	IL5RA	interleukin 5 receptor, alpha
F14.4	NM_005043	No description available
K15.3	GDNF	glial cell derived neurotrophic factor
K13.4	PTGS2	prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
J04.2	CD9	CD9 antigen (p24)
D04.4	HES2	hairy and enhancer of split (Drosophila) homolog 2
D17.4	SHH	sonic hedgehog homolog (Drosophila)
M04.1	CCBP2	chemokine binding protein 2
I16.4	MADCAM1	mucosal vascular addressin cell adhesion molecule 1
D04.2	SMO	smoothened homolog (Drosophila)
L17.2	ADAM9	a disintegrin and metalloproteinase domain 9 (meltrin gamma)
F13.4	RFNG	radical fringe homolog (Drosophila)
F20.4	HCRTR2	hypocretin (orexin) receptor 2
M20.2	MERTK	c-mer proto-oncogene tyrosine kinase
L16.4	MAP2K1	mitogen-activated protein kinase kinase 1
N20.4	RIPK3	receptor-interacting serine-threonine kinase 3
D20.2	PPP2R2A	protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), alpha isoform
K14.4	FCER1A	Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
L12.3	ICAM3	intercellular adhesion molecule 3
L11.4	AKT3	v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma)
M13.2	RBBP4	retinoblastoma binding protein 4
H17.4	CNR2	cannabinoid receptor 2 (macrophage)
D10.3	CDC2L5	cell division cycle 2-like 5 (cholinesterase-related cell division controller)
C12.3	NGFB	nerve growth factor, beta polypeptide
J19.1	CASP1	caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase)
K16.1	PLG	plasminogen
D09.1	ACVRL1	activin A receptor type II-like 1
I13.2	PAK1	p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast)
C16.1	IL13RA2	interleukin 13 receptor, alpha 2
K09.3	SCYE1	small inducible cytokine subfamily E, member 1 (endothelial monocyte-activating)
M19.2	TNFRSF10D	tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
C15.1	NRN1	neuritin 1
I13.1	TNFRSF9	tumor necrosis factor receptor superfamily, member 9
E20.2	ANGPTL1	angiopoietin-like 1
C07.1	KDR	kinase insert domain receptor (a type III receptor tyrosine kinase)
L20.1	SUMO1	SMT3 suppressor of mif two 3 homolog 1 (yeast)
E21.3	IL3	interleukin 3 (colony-stimulating factor, multiple)
E06.4	DEFA5	defensin, alpha 5, Paneth cell-specific
G07.4	ALOX5	arachidonate 5-lipoxygenase
E14.1	MMP10	matrix metalloproteinase 10 (stromelysin 2)
C06.1	VCAM1	vascular cell adhesion molecule 1
G20.1	CDH12	cadherin 12, type 2 (N-cadherin 2)
F21.4	IL22	interleukin 22
D06.2	CCNG1	cyclin G1
L09.1	GPR3	G protein-coupled receptor 3
C04.2	CDK2	cyclin-dependent kinase 2
N09.2	CCL20	chemokine (C-C motif) ligand 20
C21.4	INPP5D	inositol polyphosphate-5-phosphatase, 145kDa
N05.3	INHBB	inhibin, beta B (activin AB beta polypeptide)
K16.3	OSMR	oncostatin M receptor
H19.2	SPARC	secreted protein, acidic, cysteine-rich (osteonectin)
F13.2	BAMBI	BMP and activin membrane-bound inhibitor homolog (Xenopus laevis)
M07.3	SLIT3	slit homolog 3 (Drosophila)
J09.1	CMKLR1	chemokine-like receptor 1
M15.2	RBBP6	retinoblastoma binding protein 6
H14.4	MAPK10	mitogen-activated protein kinase 10
L07.2	PSEN2	presenilin 2 (Alzheimer disease 4)
G15.2	IL12RB2	interleukin 12 receptor, beta 2
L13.2	FCMD	Fukuyama type congenital muscular dystrophy (fukutin)
H12.1	ITGB2	integrin, beta 2 (antigen CD18 (p95), lymphocyte function-associated antigen 1; macrophage antigen 1 (mac-1) beta subunit)
F07.2	LY96	lymphocyte antigen 96
J07.1	IL1A	interleukin 1, alpha
I12.2	LBP	lipopolysaccharide binding protein
M12.1	CDH5	cadherin 5, type 2, VE-cadherin (vascular epithelium)
L09.2	IL7R	interleukin 7 receptor
H12.2	IL1F6	interleukin 1 family, member 6 (epsilon)
N05.1	IL1RN	interleukin 1 receptor antagonist
J18.2	AMFR	autocrine motility factor receptor
D12.2	IL17R	interleukin 17 receptor
M11.3	EPO	erythropoietin
F20.3	FGF5	fibroblast growth factor 5
D15.4	JAG1	jagged 1 (Alagille syndrome)
F19.3	TNFRSF14	tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)
D15.3	NOS3	nitric oxide synthase 3 (endothelial cell)
M07.2	IL12A	interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35)
I08.4	GRB14	growth factor receptor-bound protein 14
G04.3	XCL1	chemokine (C motif) ligand 1
C04.4	CART	cocaine- and amphetamine-regulated transcript
D13.2	CCL27	chemokine (C-C motif) ligand 27
D08.1	TRAF3	TNF receptor-associated factor 3
N04.2	SOCS3	suppressor of cytokine signaling 3
I11.4	NEK2	NIMA (never in mitosis gene a)-related kinase 2
N15.1	EFNA2	ephrin-A2
M19.1	TIMP4	tissue inhibitor of metalloproteinase 4
K13.1	CCL24	chemokine (C-C motif) ligand 24
C04.3	NTRK2	neurotrophic tyrosine kinase, receptor, type 2
N06.1	TRAF2	TNF receptor-associated factor 2
I05.2	MAP3K5	mitogen-activated protein kinase kinase kinase 5
J16.3	UBB	ubiquitin B
H04.2	SOCS5	suppressor of cytokine signaling 5
C18.2	CCL26	chemokine (C-C motif) ligand 26
J04.1	FGFR4	fibroblast growth factor receptor 4
G10.1	MUSK	muscle, skeletal, receptor tyrosine kinase
K07.3	CCNF	cyclin F
N13.4	CDC25A	cell division cycle 25A
E16.3	PGF	placental growth factor, vascular endothelial growth factor-related protein
G10.4	PTPN7	protein tyrosine phosphatase, non-receptor type 7
H09.4	NR3C1	nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
E11.4	PLA2G4A	phospholipase A2, group IVA (cytosolic, calcium-dependent)
E06.2	TIAF1	TGFB1-induced anti-apoptotic factor 1
I19.4	DLL4	delta-like 4 (Drosophila)
F10.3	MAPK1	mitogen-activated protein kinase 1
G06.3	BMP7	bone morphogenetic protein 7 (osteogenic protein 1)
H15.2	TLR6	toll-like receptor 6
M05.4	BMPR2	bone morphogenetic protein receptor, type II (serine/threonine kinase)
C11.3	HMGA2	high mobility group AT-hook 2
C16.2	IGFBP1	insulin-like growth factor binding protein 1
D16.3	CCNK	cyclin K
M14.1	MMP12	matrix metalloproteinase 12 (macrophage elastase)
K06.1	SELL	selectin L (lymphocyte adhesion molecule 1)
L08.3	MAP3K7	mitogen-activated protein kinase kinase kinase 7
G05.1	IL12RB1	interleukin 12 receptor, beta 1
F16.2	HCRT	hypocretin (orexin) neuropeptide precursor
N10.1	IL13	interleukin 13
E13.3	PLAUR	plasminogen activator, urokinase receptor
C06.3	FURIN	furin (paired basic amino acid cleaving enzyme)
M08.3	ACVR1	activin A receptor, type I
G14.1	MMP13	matrix metalloproteinase 13 (collagenase 3)
D06.4	ABL1	v-abl Abelson murine leukemia viral oncogene homolog 1
E17.1	NRTN	neurturin
N10.2	ADAM15	a disintegrin and metalloproteinase domain 15 (metargidin)
E08.4	PTPN2	protein tyrosine phosphatase, non-receptor type 2
I10.4	PTPN9	protein tyrosine phosphatase, non-receptor type 9
M13.1	CTGF	connective tissue growth factor
H15.3	MMP3	matrix metalloproteinase 3 (stromelysin 1, progelatinase)
L17.3	FLT3	fms-related tyrosine kinase 3
N16.4	PIAS3	protein inhibitor of activated STAT, 3
H18.1	ITGAE	integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
H12.4	NM_015524	No description available
H10.3	WEE1	WEE1 homolog (S. pombe)
L10.3	HDAC5	histone deacetylase 5
K12.2	GPR21	G protein-coupled receptor 21
D09.4	PRTN3	proteinase 3 (serine proteinase, neutrophil, Wegener granulomatosis autoantigen)
M18.4	IRS1	insulin receptor substrate 1
K05.1	SPP1	secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1)
J10.1	ITGB8	integrin, beta 8
C14.2	TNFRSF6B	tumor necrosis factor receptor superfamily, member 6b, decoy
H17.2	EP300	E1A binding protein p300
G17.1	GFRA2	GDNF family receptor alpha 2
M06.2	AGRN	agrin
F17.2	FBLN5	fibulin 5
E14.2	CYCS	cytochrome c, somatic
I04.3	BTC	betacellulin
F21.3	PDGFRA	platelet-derived growth factor receptor, alpha polypeptide
N20.3	PODXL	podocalyxin-like
I09.2	DAPK1	death-associated protein kinase 1
H19.4	STAT6	signal transducer and activator of transcription 6, interleukin-4 induced
L04.1	FADD	Fas (TNFRSF6)-associated via death domain
I13.3	IL2	interleukin 2
H19.1	EPHA4	EphA4
N09.3	IFNG	interferon, gamma
M09.3	ANGPTL3	angiopoietin-like 3
E12.1	TNFRSF11A	tumor necrosis factor receptor superfamily, member 11a, activator of NFKB
G21.1	GFRA1	GDNF family receptor alpha 1
N22.2	AE000430	No description available
N05.2	PSEN1	presenilin 1 (Alzheimer disease 3)
I05.4	FGF6	fibroblast growth factor 6
H11.4	OGT	O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase)
F06.3	MET	met proto-oncogene (hepatocyte growth factor receptor)
F19.2	CDK5	cyclin-dependent kinase 5
E17.2	ARID4A	AT rich interactive domain 4A (RBP1-like)
J13.4	AATK	apoptosis-associated tyrosine kinase
C21.3	IL4R	interleukin 4 receptor
D11.4	STAT5A	signal transducer and activator of transcription 5A
F11.3	CCL11	chemokine (C-C motif) ligand 11
K18.2	APP	amyloid beta (A4) precursor protein (protease nexin-II, Alzheimer disease)
G09.3	CCNG2	cyclin G2
D22.2	PPIA	peptidylprolyl isomerase A (cyclophilin A)
K09.2	FGFR1	fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome)
N13.3	IL11	interleukin 11
H07.1	IL13RA1	interleukin 13 receptor, alpha 1
I06.3	IL9R	interleukin 9 receptor
H05.1	FST	follistatin
F19.1	EFNB2	ephrin-B2
K17.1	CXCR6	chemokine (C-X-C motif) receptor 6
F15.2	TERT	telomerase reverse transcriptase
L08.2	SKIL	SKI-like
I09.1	CCR5	chemokine (C-C motif) receptor 5
G07.2	GPR4	G protein-coupled receptor 4
C17.4	CR1	complement component (3b/4b) receptor 1, including Knops blood group system
L06.2	DKK3	dickkopf homolog 3 (Xenopus laevis)
L06.4	RBPSUH	recombining binding protein suppressor of hairless (Drosophila)
N19.4	DLL1	delta-like 1 (Drosophila)
C19.2	MYC	v-myc myelocytomatosis viral oncogene homolog (avian)
J17.4	AGTR2	angiotensin II receptor, type 2
C21.1	PAEP	progestagen-associated endometrial protein (placental protein 14, pregnancy-associated endometrial alpha-2-globulin, alpha uterine protein)
K07.2	CHUK	conserved helix-loop-helix ubiquitous kinase
H14.1	ITGA9	integrin, alpha 9
H13.3	DCN	decorin
F04.1	FGFR3	fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism)
F04.4	PTX3	pentaxin-related gene, rapidly induced by IL-1 beta
L13.4	BLK	B lymphoid tyrosine kinase
N15.3	CCL19	chemokine (C-C motif) ligand 19
E13.2	GAS6	growth arrest-specific 6
D17.3	TGFBR3	transforming growth factor, beta receptor III (betaglycan, 300kDa)
D19.2	WISP2	WNT1 inducible signaling pathway protein 2
G04.2	IGF2	insulin-like growth factor 2 (somatomedin A)
C14.1	CDH3	cadherin 3, type 1, P-cadherin (placental)
L05.2	ATRN	attractin
F20.2	GCNT1	glucosaminyl (N-acetyl) transferase 1, core 2 (beta-1,6-N-acetylglucosaminyltransferase)
G16.3	TGFBR2	transforming growth factor, beta receptor II (70/80kDa)
F16.1	PTGS1	prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
M12.4	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)
K10.1	IGFBP7	insulin-like growth factor binding protein 7
C22.2	B2M	beta-2-microglobulin
D07.3	PPBP	pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
E09.4	ADORA1	adenosine A1 receptor
G05.3	CDK9	cyclin-dependent kinase 9 (CDC2-related kinase)
E07.2	CD40LG	CD40 ligand (TNF superfamily, member 5, hyper-IgM syndrome)
J13.3	IL2RA	interleukin 2 receptor, alpha
H06.3	LTB	lymphotoxin beta (TNF superfamily, member 3)
G17.2	CNTFR	ciliary neurotrophic factor receptor
E16.1	MMP15	matrix metalloproteinase 15 (membrane-inserted)
M09.4	MAPK7	mitogen-activated protein kinase 7
G19.1	TIMP1	tissue inhibitor of metalloproteinase 1 (erythroid potentiating activity, collagenase inhibitor)
F17.1	EPHA3	EphA3
D15.1	GPR17	G protein-coupled receptor 17
E20.1	CDH11	cadherin 11, type 2, OB-cadherin (osteoblast)
H11.3	IL1R2	interleukin 1 receptor, type II
L04.2	SOCS2	suppressor of cytokine signaling 2
I13.4	GDF2	growth differentiation factor 2
M08.1	GRB2	growth factor receptor-bound protein 2
D17.2	NGFR	nerve growth factor receptor (TNFR superfamily, member 16)
M19.4	TNFRSF17	tumor necrosis factor receptor superfamily, member 17
E09.3	TP73	tumor protein p73
N14.3	CLK1	CDC-like kinase 1
L10.2	E2F1	E2F transcription factor 1
H09.3	GFRA3	GDNF family receptor alpha 3
M14.2	MAP3K14	mitogen-activated protein kinase kinase kinase 14
I12.4	ACACB	acetyl-Coenzyme A carboxylase beta
C13.1	GPR30	G protein-coupled receptor 30
L04.4	DAB2	disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila)
N20.2	PTK7	PTK7 protein tyrosine kinase 7
N14.4	PML	promyelocytic leukemia
K05.2	BMP10	bone morphogenetic protein 10
J11.3	ERBB4	v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)
D13.4	MFNG	manic fringe homolog (Drosophila)
G04.1	IGFBP6	insulin-like growth factor binding protein 6
L12.4	UCP1	uncoupling protein 1 (mitochondrial, proton carrier)
I21.4	IRAK2	interleukin-1 receptor-associated kinase 2
C12.1	CDH2	cadherin 2, type 1, N-cadherin (neuronal)
L14.3	IL1R1	interleukin 1 receptor, type I
I04.4	DEFA1	defensin, alpha 1, myeloid-related sequence
F07.4	RNASE3	ribonuclease, RNase A family, 3 (eosinophil cationic protein)
N17.1	EPHB4	EphB4
C04.1	MMP1	matrix metalloproteinase 1 (interstitial collagenase)
C17.3	FGF17	fibroblast growth factor 17
J08.4	MAP2K4	mitogen-activated protein kinase kinase 4
M11.2	IL18RAP	interleukin 18 receptor accessory protein
L07.4	STAT4	signal transducer and activator of transcription 4
I10.1	IFNB1	interferon, beta 1, fibroblast
G18.2	TNFRSF4	tumor necrosis factor receptor superfamily, member 4
M09.1	DNCL1	dynein, cytoplasmic, light polypeptide 1
M15.4	CD3E	CD3E antigen, epsilon polypeptide (TiT3 complex)
G15.1	IFNAR2	interferon (alpha, beta and omega) receptor 2
N15.4	FASTK	FAST kinase
M10.3	CCL3	chemokine (C-C motif) ligand 3
J19.4	JUNB	jun B proto-oncogene
H21.2	LTBP3	latent transforming growth factor beta binding protein 3
H19.3	VEGF	vascular endothelial growth factor
E12.2	GAS1	growth arrest-specific 1
N09.1	GPR1	G protein-coupled receptor 1
H05.4	CD53	CD53 antigen
E15.1	ANGPT1	angiopoietin 1
F06.4	RELN	reelin
M15.3	NTRK1	neurotrophic tyrosine kinase, receptor, type 1
J08.3	SELP	selectin P (granule membrane protein 140kDa, antigen CD62)
J17.2	CDK6	cyclin-dependent kinase 6
G07.3	CCND3	cyclin D3
L05.3	LEPR	leptin receptor
I11.2	NFKB2	nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
C16.4	PAK4	p21(CDKN1A)-activated kinase 4
E21.4	BACE1	beta-site APP-cleaving enzyme 1
N20.1	LRRFIP1	leucine rich repeat (in FLII) interacting protein 1
M17.2	CDC2	cell division cycle 2, G1 to S and G2 to M
L07.3	LIFR	leukemia inhibitory factor receptor
J21.2	TINF2	TERF1 (TRF1)-interacting nuclear factor 2
H09.2	IL1B	interleukin 1, beta
F05.1	CD6	CD6 antigen
L18.4	NME5	non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase)
G18.4	SLC25A27	solute carrier family 25, member 27
F11.2	PBEF1	pre-B-cell colony enhancing factor 1
E19.1	TIE1	tyrosine kinase with immunoglobulin-like and EGF-like domains 1
H08.4	PDGFC	platelet derived growth factor C
C20.1	LEFTY2	left-right determination factor 2
C21.2	TNFRSF18	tumor necrosis factor receptor superfamily, member 18
F09.2	CXCL1	chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
L06.1	TANK	TRAF family member-associated NFKB activator
H14.2	ITPR1	inositol 1,4,5-triphosphate receptor, type 1
G20.3	FGF12	fibroblast growth factor 12
J10.2	SOCS1	suppressor of cytokine signaling 1
H07.3	BSG	basigin (OK blood group)
M08.2	SERPINB9	serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 9
L13.1	TP53	tumor protein p53 (Li-Fraumeni syndrome)
D09.3	TNFRSF8	tumor necrosis factor receptor superfamily, member 8
K20.3	CXCL13	chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant)
G16.2	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)
J11.4	KIF20A	kinesin family member 20A
J05.2	TNF	tumor necrosis factor (TNF superfamily, member 2)
D20.3	SLIT1	slit homolog 1 (Drosophila)
M12.3	CCL14	chemokine (C-C motif) ligand 14
D19.3	CX3CR1	chemokine (C-X3-C motif) receptor 1
I16.1	ALCAM	activated leukocyte cell adhesion molecule
I09.3	CCNI	cyclin I
C11.1	TNFRSF25	tumor necrosis factor receptor superfamily, member 25
E07.1	NTRK3	neurotrophic tyrosine kinase, receptor, type 3
G09.1	CX3CL1	chemokine (C-X3-C motif) ligand 1
C15.4	CLK3	CDC-like kinase 3
H18.3	TEP1	telomerase-associated protein 1
F17.4	CNR1	cannabinoid receptor 1 (brain)
M19.3	CSF3R	colony stimulating factor 3 receptor (granulocyte)
E09.2	MDM2	Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse)
I10.2	FAS	Fas (TNF receptor superfamily, member 6)
K14.1	SFRP1	secreted frizzled-related protein 1
J17.3	AREG	amphiregulin (schwannoma-derived growth factor)
J09.3	FASLG	Fas ligand (TNF superfamily, member 6)
I07.3	CCNE2	cyclin E2
M18.2	CCL5	chemokine (C-C motif) ligand 5
K11.3	ANG	angiogenin, ribonuclease, RNase A family, 5
L20.4	PTCH	patched homolog (Drosophila)
I14.4	PTPN13	protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
D19.1	CRADD	CASP2 and RIPK1 domain containing adaptor with death domain
H13.1	STK17B	serine/threonine kinase 17b (apoptosis-inducing)
C05.3	F2R	coagulation factor II (thrombin) receptor
C17.2	RBBP5	retinoblastoma binding protein 5
D07.2	IFNGR2	interferon gamma receptor 2 (interferon gamma transducer 1)
C10.3	INHBA	inhibin, beta A (activin A, activin AB alpha polypeptide)
K06.3	HBEGF	heparin-binding EGF-like growth factor
N17.2	CDK4	cyclin-dependent kinase 4
C07.4	PODXL2	podocalyxin-like 2
E04.3	NTF5	neurotrophin 5 (neurotrophin 4/5)
G12.4	ACACA	acetyl-Coenzyme A carboxylase alpha
K17.4	DOK2	docking protein 2, 56kDa
C13.2	AVP	arginine vasopressin (neurophysin II, antidiuretic hormone, diabetes insipidus, neurohypophyseal)
D08.4	GLI1	glioma-associated oncogene homolog 1 (zinc finger protein)
N08.2	TGFBRAP1	transforming growth factor, beta receptor associated protein 1
H04.4	MYD88	myeloid differentiation primary response gene (88)
J20.3	PTK2	PTK2 protein tyrosine kinase 2
G19.3	EDA	ectodysplasin A
D09.2	CD40	CD40 antigen (TNF receptor superfamily member 5)
E09.1	CCR3	chemokine (C-C motif) receptor 3
I04.1	IL18R1	interleukin 18 receptor 1
K20.4	MLYCD	malonyl-CoA decarboxylase
J11.2	ANGPTL2	angiopoietin-like 2
F12.2	ARTN	artemin
M10.1	TNFSF12	tumor necrosis factor (ligand) superfamily, member 12
E10.4	CHEK1	CHK1 checkpoint homolog (S. pombe)
D17.1	EPHA2	EphA2
G05.2	RIPK2	receptor-interacting serine-threonine kinase 2
N11.1	GPR19	G protein-coupled receptor 19
E12.3	BMP2	bone morphogenetic protein 2
J05.1	SCGF	stem cell growth factor; lymphocyte secreted C-type lectin
J12.2	PPP3CB	protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform (calcineurin A beta)
E18.1	CD226	CD226 antigen
H16.2	APEX1	APEX nuclease (multifunctional DNA repair enzyme) 1
E19.2	BIK	BCL2-interacting killer (apoptosis-inducing)
K18.1	CDH8	cadherin 8, type 2
D05.1	XCR1	chemokine (C motif) receptor 1
E17.4	DOK1	docking protein 1, 62kDa (downstream of tyrosine kinase 1)
L18.3	FGF7	fibroblast growth factor 7 (keratinocyte growth factor)
N16.2	CDK7	cyclin-dependent kinase 7 (MO15 homolog, Xenopus laevis, cdk-activating kinase)
D14.4	ATP2A3	ATPase, Ca++ transporting, ubiquitous
L15.1	EFNA1	ephrin-A1
I12.1	MMP14	matrix metalloproteinase 14 (membrane-inserted)
I21.2	SELPLG	selectin P ligand
C18.3	FGF18	fibroblast growth factor 18
D11.3	CDH4	cadherin 4, type 1, R-cadherin (retinal)
J04.4	TNFRSF19	tumor necrosis factor receptor superfamily, member 19
H20.1	NM_005287	No description available
C10.2	TRAF1	TNF receptor-associated factor 1
E14.3	TDGF1	teratocarcinoma-derived growth factor 1
L14.1	TNFSF4	tumor necrosis factor (ligand) superfamily, member 4 (tax-transcriptionally activated glycoprotein 1, 34kDa)
N14.2	MAP3K7IP1	mitogen-activated protein kinase kinase kinase 7 interacting protein 1
I16.2	TNFSF13B	tumor necrosis factor (ligand) superfamily, member 13b
K12.3	BDNF	brain-derived neurotrophic factor
L17.1	NSMAF	neutral sphingomyelinase (N-SMase) activation associated factor
D14.1	ITGA8	integrin, alpha 8
C08.4	PTPN1	protein tyrosine phosphatase, non-receptor type 1
C09.4	STK6	serine/threonine kinase 6
J14.2	PTPRC	protein tyrosine phosphatase, receptor type, C
G13.4	NEK3	NIMA (never in mitosis gene a)-related kinase 3
H08.3	IL6ST	interleukin 6 signal transducer (gp130, oncostatin M receptor)
H16.3	MC4R	melanocortin 4 receptor
K04.3	CTLA4	cytotoxic T-lymphocyte-associated protein 4
G21.3	IL8RB	interleukin 8 receptor, beta
M06.4	ADAM10	a disintegrin and metalloproteinase domain 10
D21.4	MST1	macrophage stimulating 1 (hepatocyte growth factor-like)
J21.3	MPL	myeloproliferative leukemia virus oncogene
E11.1	TNFSF10	tumor necrosis factor (ligand) superfamily, member 10
K11.2	IKBKB	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
G17.3	FGF2	fibroblast growth factor 2 (basic)
M16.1	SEMA5A	sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
K05.4	CCL21	chemokine (C-C motif) ligand 21
H09.1	TNFSF13	tumor necrosis factor (ligand) superfamily, member 13
M22.4	AE000241	No description available
E07.3	LTBP4	latent transforming growth factor beta binding protein 4
H21.4	GK	glycerol kinase
L05.4	PTPN12	protein tyrosine phosphatase, non-receptor type 12
D21.1	EDN3	endothelin 3
N04.1	CXCL2	chemokine (C-X-C motif) ligand 2
K18.4	STAT1	signal transducer and activator of transcription 1, 91kDa
G14.3	EPHA1	EphA1
H06.1	EDNRB	endothelin receptor type B
F08.3	PTN	pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1)
H17.3	IL16	interleukin 16 (lymphocyte chemoattractant factor)
L08.4	MAP2K6	mitogen-activated protein kinase kinase 6
D07.4	IL17RB	interleukin 17 receptor B
E05.2	DFFB	DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)
E10.3	LIF	leukemia inhibitory factor (cholinergic differentiation factor)
D21.2	LTBP1	latent transforming growth factor beta binding protein 1
I14.2	RB1	retinoblastoma 1 (including osteosarcoma)
E07.4	CCRL1	chemokine (C-C motif) receptor-like 1
K20.1	IL1RL1	interleukin 1 receptor-like 1
E13.4	CLK2	CDC-like kinase 2
C11.2	RARB	retinoic acid receptor, beta
I20.1	MCAM	melanoma cell adhesion molecule
M18.3	CCL25	chemokine (C-C motif) ligand 25
J20.4	IRF1	interferon regulatory factor 1
E15.2	FLT4	fms-related tyrosine kinase 4
G18.1	TGFB2	transforming growth factor, beta 2
G09.2	BCL10	B-cell CLL/lymphoma 10
C10.4	PTPN6	protein tyrosine phosphatase, non-receptor type 6
N12.4	CBL	Cas-Br-M (murine) ecotropic retroviral transforming sequence
H18.2	CCNH	cyclin H
J11.1	CMKOR1	chemokine orphan receptor 1
I04.2	SERPINB8	serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 8
G19.2	FLT1	fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor)
I14.3	NOTCH3	Notch homolog 3 (Drosophila)
F12.1	ITGB3	integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
J14.4	TRAF3IP1	TNF receptor-associated factor 3 interacting protein 1
C20.2	CCL2	chemokine (C-C motif) ligand 2
H21.1	MADD	MAP-kinase activating death domain
M10.4	PTPN14	protein tyrosine phosphatase, non-receptor type 14
J18.1	FGF1	fibroblast growth factor 1 (acidic)
E08.1	PECAM1	platelet/endothelial cell adhesion molecule (CD31 antigen)
I08.1	IL15RA	interleukin 15 receptor, alpha
M06.1	IL10RB	interleukin 10 receptor, beta
G11.4	PLK1	polo-like kinase 1 (Drosophila)
G21.2	IGF1	insulin-like growth factor 1 (somatomedin C)
D04.1	GLG1	golgi apparatus protein 1
I07.4	APPBP1	amyloid beta precursor protein binding protein 1, 59kDa
H12.3	IL10	interleukin 10
K12.4	CXCR3	chemokine (C-X-C motif) receptor 3
D06.3	IL2RB	interleukin 2 receptor, beta
D14.2	BAD	BCL2-antagonist of cell death
N08.3	LAMR1	laminin receptor 1 (ribosomal protein SA, 67kDa)
I21.3	ICAM1	intercellular adhesion molecule 1 (CD54), human rhinovirus receptor
C19.1	ANGPT2	angiopoietin 2
H08.2	FOXH1	forkhead box H1
J05.4	DEFB4	defensin, beta 4
H20.3	CCR6	chemokine (C-C motif) receptor 6
I17.4	C3	complement component 3
L11.1	IL8	interleukin 8
D05.2	HMGB1	high-mobility group box 1
M05.1	IL11RA	interleukin 11 receptor, alpha
J09.4	RPL22	ribosomal protein L22
G07.1	NOS1	nitric oxide synthase 1 (neuronal)
L15.2	TLR4	toll-like receptor 4
L06.3	CXCL9	chemokine (C-X-C motif) ligand 9
C15.3	CSF3	colony stimulating factor 3 (granulocyte)
H07.2	CXCL12	chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1)
D11.2	IL12B	interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)
K04.2	NM_001758	No description available
H16.4	CDKN2D	cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)
F09.4	IGSF1	immunoglobulin superfamily, member 1
G14.2	CDKN2A	cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)
C13.3	CCR2	chemokine (C-C motif) receptor 2
L10.4	NOTCH2	Notch homolog 2 (Drosophila)
M04.4	DEFA4	defensin, alpha 4, corticostatin
K07.4	KITLG	KIT ligand
J06.1	CCL16	chemokine (C-C motif) ligand 16
N16.3	GMFB	glia maturation factor, beta
E17.3	IL6	interleukin 6 (interferon, beta 2)
J16.4	PLAU	plasminogen activator, urokinase
E12.4	PTPN22	protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
J12.1	ITGA3	integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
C07.3	CCNB1	cyclin B1
F20.1	GPR68	G protein-coupled receptor 68
J14.3	MDK	midkine (neurite growth-promoting factor 2)
K09.4	PF4	platelet factor 4 (chemokine (C-X-C motif) ligand 4)
E14.4	ITGAX	integrin, alpha X (antigen CD11C (p150), alpha polypeptide)
K10.2	INSR	insulin receptor
C05.2	BAG1	BCL2-associated athanogene
M11.4	DKK4	dickkopf homolog 4 (Xenopus laevis)
L15.3	BMP8B	bone morphogenetic protein 8b (osteogenic protein 2)
D22.4	GAPD	glyceraldehyde-3-phosphate dehydrogenase
G12.1	CDH1	cadherin 1, type 1, E-cadherin (epithelial)
D14.3	HDAC6	histone deacetylase 6
K04.1	ICAM2	intercellular adhesion molecule 2
F05.3	CCL18	chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
M17.1	GPR15	G protein-coupled receptor 15
C14.4	CD3Z	CD3Z antigen, zeta polypeptide (TiT3 complex)
H05.2	VEGFC	vascular endothelial growth factor C
L20.2	MNAT1	menage a trois 1 (CAK assembly factor)
D20.1	GZMB	granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
E15.3	PDGFB	platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog)
F04.3	BLR1	Burkitt lymphoma receptor 1, GTP binding protein (chemokine (C-X-C motif) receptor 5)
G08.3	CSF1R	colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog
M08.4	CAMP	cathelicidin antimicrobial peptide
E19.3	CDH6	cadherin 6, type 2, K-cadherin (fetal kidney)
E08.2	TNFRSF10C	tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
E08.3	IFNAR1	interferon (alpha, beta and omega) receptor 1
G17.4	CTNNB1	catenin (cadherin-associated protein), beta 1, 88kDa
D18.1	ITGA6	integrin, alpha 6
F17.3	HGF	hepatocyte growth factor (hepapoietin A; scatter factor)
F18.3	CCL4	chemokine (C-C motif) ligand 4
K15.2	IL4	interleukin 4
K20.2	CCR10	chemokine (C-C motif) receptor 10
D16.2	NEUROG3	neurogenin 3
F14.1	ITGAV	integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51)
F15.1	SFRP2	secreted frizzled-related protein 2
M11.1	CCR8	chemokine (C-C motif) receptor 8
N11.3	ERBB3	v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)
F14.3	HDAC4	histone deacetylase 4
I19.2	CD4	CD4 antigen (p55)
L19.4	IKBKG	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
K13.3	PDGFA	platelet-derived growth factor alpha polypeptide
C06.4	DEFA6	defensin, alpha 6, Paneth cell-specific
G12.2	IL1RL2	interleukin 1 receptor-like 2
E18.3	CSF2RB	colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
N08.4	TFDP2	transcription factor Dp-2 (E2F dimerization partner 2)
I18.4	TPS1	tryptase, alpha
L12.2	SERPINE1	serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
K08.2	FAIM3	Fas apoptotic inhibitory molecule 3 /// Fas apoptotic inhibitory molecule 3
E15.4	GFRA4	GDNF family receptor alpha 4
M16.3	CR2	complement component (3d/Epstein Barr virus) receptor 2
F07.1	TGFA	transforming growth factor, alpha
N12.1	ITGA7	integrin, alpha 7
L16.2	SERPINB5	serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 5
L14.4	PTPRB	protein tyrosine phosphatase, receptor type, B
C08.1	IGFBP5	insulin-like growth factor binding protein 5
N06.4	SRP72	signal recognition particle 72kDa
K16.4	PRKCB1	protein kinase C, beta 1
N07.4	NFKBIE	nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon
N04.3	CD38	CD38 antigen (p45)
E22.4	HPRT1	hypoxanthine phosphoribosyltransferase 1 (Lesch-Nyhan syndrome)
F13.3	LEP	leptin (obesity homolog, mouse)
C19.3	EFNA3	ephrin-A3
F05.2	IFNGR1	interferon gamma receptor 1
G16.4	NTN2L	netrin 2-like (chicken)
H20.2	HDAC1	histone deacetylase 1
M07.4	FZD2	frizzled homolog 2 (Drosophila)
J06.3	THPO	thrombopoietin (myeloproliferative leukemia virus oncogene ligand, megakaryocyte growth and development factor)
I20.2	TNFSF15	tumor necrosis factor (ligand) superfamily, member 15
D06.1	CXCL3	chemokine (C-X-C motif) ligand 3
J15.4	IRS2	insulin receptor substrate 2
I07.1	FCGR1A	Fc fragment of IgG, high affinity Ia, receptor for (CD64)
I06.2	BCL2L2	BCL2-like 2
I15.4	MAPK14	mitogen-activated protein kinase 14
L18.2	INSRR	insulin receptor-related receptor
K13.2	TNFSF18	tumor necrosis factor (ligand) superfamily, member 18
G13.2	LTA	lymphotoxin alpha (TNF superfamily, member 1)
G10.2	YWHAZ	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
G16.1	LU	Lutheran blood group (Auberger b antigen included)
J20.1	PTEN	phosphatase and tensin homolog (mutated in multiple advanced cancers 1)
F06.2	PDCD1LG1	programmed cell death 1 ligand 1
M20.3	CCL15	chemokine (C-C motif) ligand 15
G05.4	CCL8	chemokine (C-C motif) ligand 8
C11.4	MAPK6	mitogen-activated protein kinase 6
D12.1	ITGA4	integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
G15.3	FGF9	fibroblast growth factor 9 (glia-activating factor)
J21.1	FGFR2	fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome)
I18.1	ASIP	agouti signaling protein, nonagouti homolog (mouse)
G15.4	CDKL1	cyclin-dependent kinase-like 1 (CDC2-related kinase)
H07.4	ADAM19	a disintegrin and metalloproteinase domain 19 (meltrin beta)
J13.1	TNFSF14	tumor necrosis factor (ligand) superfamily, member 14
E04.4	FOS	v-fos FBJ murine osteosarcoma viral oncogene homolog
D08.2	IL1F5	interleukin 1 family, member 5 (delta)
G11.1	CD34	CD34 antigen
K06.4	PTPN5	protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched)
I14.1	GDF15	growth differentiation factor 15
J20.2	HDAC2	histone deacetylase 2
M17.3	IL26	interleukin 26
C20.3	FGF13	fibroblast growth factor 13
C08.2	ADAM17	a disintegrin and metalloproteinase domain 17 (tumor necrosis factor, alpha, converting enzyme)
F22.2	RPL19	ribosomal protein L19
J15.1	EPHB2	EphB2
K19.1	RET	ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease)
J05.3	CCL23	chemokine (C-C motif) ligand 23
I11.3	IL1F8	interleukin 1 family, member 8 (eta)
C12.4	PTPN21	protein tyrosine phosphatase, non-receptor type 21
E16.4	PAK2	p21 (CDKN1A)-activated kinase 2
D18.2	EDAR	ectodysplasin 1, anhidrotic receptor
M13.4	DKK1	dickkopf homolog 1 (Xenopus laevis)
F18.1	ITGAL	integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
I05.1	EGFR	epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
E10.2	RXRB	retinoid X receptor, beta
C09.1	CCR4	chemokine (C-C motif) receptor 4
F18.4	CDK5R2	cyclin-dependent kinase 5, regulatory subunit 2 (p39)
G06.1	MMP8	matrix metalloproteinase 8 (neutrophil collagenase)
E19.4	BCL3	B-cell CLL/lymphoma 3
C18.1	IL1RAP	interleukin 1 receptor accessory protein
J08.2	ZFYVE9	zinc finger, FYVE domain containing 9
G09.4	FNTA	farnesyltransferase, CAAX box, alpha
G10.3	IL17	interleukin 17 (cytotoxic T-lymphocyte-associated serine esterase 8)
E11.3	CER1	cerberus 1 homolog, cysteine knot superfamily (Xenopus laevis)
C17.1	LTBR	lymphotoxin beta receptor (TNFR superfamily, member 3)
F21.2	LTBP2	latent transforming growth factor beta binding protein 2
H15.4	EGR1	early growth response 1
D10.2	TLR5	toll-like receptor 5
F10.4	MAPK8	mitogen-activated protein kinase 8
L09.3	FGF10	fibroblast growth factor 10
K10.3	CNTF	ciliary neurotrophic factor
F08.4	GLI3	GLI-Kruppel family member GLI3 (Greig cephalopolysyndactyly syndrome)
L08.1	ITGB6	integrin, beta 6
L11.2	LY64	lymphocyte antigen 64 homolog, radioprotective 105kDa (mouse)
C20.4	MS4A2	membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for; beta polypeptide)
D11.1	ALPP	alkaline phosphatase, placental (Regan isozyme)
M05.3	CCNA1	cyclin A1
D05.3	FIGF	c-fos induced growth factor (vascular endothelial growth factor D)
I17.3	TGFB1	transforming growth factor, beta 1 (Camurati-Engelmann disease)
C09.2	LGALS3	lectin, galactoside-binding, soluble, 3 (galectin 3)
D12.3	SH2D2A	SH2 domain protein 2A
N17.4	NME6	non-metastatic cells 6, protein expressed in (nucleoside-diphosphate kinase)
H11.1	PRL	prolactin
L16.1	TRAF5	TNF receptor-associated factor 5
E11.2	TP53BP2	tumor protein p53 binding protein, 2
J06.2	PRKCA	protein kinase C, alpha
D05.4	GPR	putative G protein coupled receptor
H10.1	ITGB7	integrin, beta 7
F14.2	WIF1	WNT inhibitory factor 1
M10.2	BID	BH3 interacting domain death agonist
K19.2	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)
K08.3	ACVR2	activin A receptor, type II
J12.3	FRZB	frizzled-related protein
E21.1	TNFRSF10B	tumor necrosis factor receptor superfamily, member 10b
N13.2	CHRM3	cholinergic receptor, muscarinic 3
D16.1	NRP1	neuropilin 1
K15.1	TNFRSF10A	tumor necrosis factor receptor superfamily, member 10a
G06.4	DEFB1	defensin, beta 1
H04.1	TRADD	TNFRSF1A-associated via death domain
K08.4	CCNT1	cyclin T1
N07.1	DLK1	delta-like 1 homolog (Drosophila)
N08.1	ITGB1	integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
F10.1	ITGB5	integrin, beta 5
L15.4	GAB1	GRB2-associated binding protein 1
J07.4	PLA2G10	phospholipase A2, group X
E20.4	UCP2	uncoupling protein 2 (mitochondrial, proton carrier)
L18.1	ITGAM	integrin, alpha M (complement component receptor 3, alpha; also known as CD11b (p170), macrophage antigen alpha polypeptide)
K11.4	ANGPT4	angiopoietin 4
E10.1	TEK	TEK tyrosine kinase, endothelial (venous malformations, multiple cutaneous and mucosal)
N18.3	DAPK3	death-associated protein kinase 3
N14.1	TNFSF9	tumor necrosis factor (ligand) superfamily, member 9
E18.2	FGF8	fibroblast growth factor 8 (androgen-induced)
K18.3	TACSTD2	tumor-associated calcium signal transducer 2
G14.4	LTF	lactotransferrin
H18.4	IL22RA1	interleukin 22 receptor, alpha 1
N12.2	NPY	neuropeptide Y
F09.1	LSAMP	limbic system-associated membrane protein
K04.4	ADAM28	a disintegrin and metalloproteinase domain 28
D20.4	HCRTR1	hypocretin (orexin) receptor 1
G08.1	SELE	selectin E (endothelial adhesion molecule 1)
H17.1	EPHB3	EphB3
N11.2	LY86	lymphocyte antigen 86
L13.3	IL6R	interleukin 6 receptor
I15.3	CD8A	CD8 antigen, alpha polypeptide (p32)
F12.3	OSM	oncostatin M
C19.4	IRAK1	interleukin-1 receptor-associated kinase 1
G08.4	PTPN3	protein tyrosine phosphatase, non-receptor type 3
H08.1	MMP9	matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)
C14.3	NM_004511	No description available
M18.1	NCAM1	neural cell adhesion molecule 1
E16.2	GPR65	G protein-coupled receptor 65
N07.3	CCL7	chemokine (C-C motif) ligand 7
L17.4	AMHR2	anti-Mullerian hormone receptor, type II
I19.1	TIMP3	tissue inhibitor of metalloproteinase 3 (Sorsby fundus dystrophy, pseudoinflammatory)
L20.3	SHC1	SHC (Src homology 2 domain containing) transforming protein 1
F11.1	NOS2A	nitric oxide synthase 2A (inducible, hepatocytes)
M04.3	TNFSF7	tumor necrosis factor (ligand) superfamily, member 7
D16.4	MAP2K5	mitogen-activated protein kinase kinase 5
N19.2	BGN	biglycan
I18.3	IGFBP4	insulin-like growth factor binding protein 4
N09.4	STAT2	signal transducer and activator of transcription 2, 113kDa
G11.2	IGF1R	insulin-like growth factor 1 receptor
N06.3	BMP3	bone morphogenetic protein 3 (osteogenic)
F18.2	WNT16	wingless-type MMTV integration site family, member 16
I21.1	TIMP2	tissue inhibitor of metalloproteinase 2
N10.3	DNAJB1	DnaJ (Hsp40) homolog, subfamily B, member 1
C22.4	ACTB	actin, beta
N18.2	PLK2	polo-like kinase 2 (Drosophila)
C05.1	ERBB2	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)
E05.4	MAPK4	mitogen-activated protein kinase 4
H14.3	EPOR	erythropoietin receptor
F10.2	GZMA	granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
C15.2	JARID1A	Jumonji, AT rich interactive domain 1A (RBBP2-like)
N05.4	PTPN18	protein tyrosine phosphatase, non-receptor type 18 (brain-derived)
I08.2	BAK1	BCL2-antagonist/killer 1
D21.3	MDM4	Mdm4, transformed 3T3 cell double minute 4, p53 binding protein (mouse)
C18.4	UCP3	uncoupling protein 3 (mitochondrial, proton carrier)
D08.3	FGF3	fibroblast growth factor 3 (murine mammary tumor virus integration site (v-int-2) oncogene homolog)
D12.4	IL19	interleukin 19
M17.4	CD3G	CD3G antigen, gamma polypeptide (TiT3 complex)
E04.1	IGFBP3	insulin-like growth factor binding protein 3
L09.4	GAK	cyclin G associated kinase
M20.4	STAT3	signal transducer and activator of transcription 3 (acute-phase response factor)
L19.3	INHA	inhibin, alpha
J12.4	GZMK	granzyme K (serine protease, granzyme 3; tryptase II)
D10.1	EPHB1	EphB1
J14.1	ITGA1	integrin, alpha 1
F15.4	IHH	Indian hedgehog homolog (Drosophila)
N19.1	EDN2	endothelin 2
M16.2	BCL2L11	BCL2-like 11 (apoptosis facilitator)
G06.2	BAX	BCL2-associated X protein
J04.3	BMPR1A	bone morphogenetic protein receptor, type IA
K11.1	AXL	AXL receptor tyrosine kinase
K07.1	KIT	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
N17.3	IL7	interleukin 7
N12.3	HDAC3	histone deacetylase 3
C05.4	MAP3K3	mitogen-activated protein kinase kinase kinase 3
I17.2	IFI27	interferon, alpha-inducible protein 27
H21.3	FLT3LG	fms-related tyrosine kinase 3 ligand
I15.1	MST1R	macrophage stimulating 1 receptor (c-met-related tyrosine kinase)
K17.2	BCL2	B-cell CLL/lymphoma 2
K12.1	IGFBP2	insulin-like growth factor binding protein 2, 36kDa
F06.1	EPHB6	EphB6
M06.3	CCL1	chemokine (C-C motif) ligand 1
J15.2	TLR3	toll-like receptor 3
K10.4	PTPN11	protein tyrosine phosphatase, non-receptor type 11 (Noonan syndrome 1)
C13.4	CKS1B	CDC28 protein kinase regulatory subunit 1B
N11.4	LFNG	lunatic fringe homolog (Drosophila)
D18.3	IL1F7	interleukin 1 family, member 7 (zeta)
C08.3	FGF16	fibroblast growth factor 16
C09.3	SLIT2	slit homolog 2 (Drosophila)
K22.2	M77789	No description available
K05.3	CCND2	cyclin D2
E05.3	CDK10	cyclin-dependent kinase (CDC2-like) 10
G19.4	C5	complement component 5
I18.2	BPI	bactericidal/permeability-increasing protein
L11.3	CD80	CD80 antigen (CD28 antigen ligand 1, B7-1 antigen)
N16.1	RIPK1	receptor (TNFRSF)-interacting serine-threonine kinase 1
H16.1	TRAF6	TNF receptor-associated factor 6
E05.1	BMP4	bone morphogenetic protein 4
G21.4	SLC25A14	solute carrier family 25 (mitochondrial carrier, brain), member 14